People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis ...

People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis who do not have COPD, according to a new study.

People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis who do not have COPD ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

After a long road that included a three-month delay as the agency pushed for additional data, the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD - as has China's National ...

The global high flow ventilators market is experiencing robust growth, driven by the increasing prevalence of respiratory diseases and a growing demand for advanced respiratory support solutions.

which was followed by green lights in the US and China. GSK's IL-5 inhibitor Nucala (mepolizumab) could also be heading for approval in COPD – at the second attempt – after reducing ...

The global oxygen conservation devices market is on an impressive growth trajectory, with industry experts forecasting a robust compound annual growth rate (CAGR) of 12% over the next decade. Valued ...